Clinical lung cancer
Re: "Re-biopsy Feasibility and Clinical Impact on Metastatic Non-Small-Cell Lung Cancer with EGFR/ALK/ROS Oncogenic Driver Progression after Optimal Targeted Therapy: A Multicenter Real-World Analysis".
Mehmet Mutlu Çatlı, Arif Hakan Önder
Published: 202510.1016/j.cllc.2025.10.017
No abstract available for this study.